# VitaFlow™ II Transcatheter Aortic Valve System Pre-market Trial

> **NCT04414878** · NA · RECRUITING · sponsor: **Shanghai MicroPort CardioFlow Medtech Co., Ltd.** · enrollment: 145 (estimated)

## Conditions studied

- Aortic Stenosis

## Interventions

- **DEVICE:** VitaFlow™ II Transcatheter Aortic Valve System

## Key facts

- **NCT ID:** NCT04414878
- **Lead sponsor:** Shanghai MicroPort CardioFlow Medtech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-01-31
- **Primary completion:** 2022-01-31
- **Final completion:** 2027-01-31
- **Target enrollment:** 145 (ESTIMATED)
- **Last updated:** 2020-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04414878

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04414878, "VitaFlow™ II Transcatheter Aortic Valve System Pre-market Trial". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04414878. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*